Amgen
Amgen sells biologic medicines such as ENBREL and Otezla, and it is indexed in the metabolic pool's GLP-1 (glucagon-like peptide-1) manufacturers layer.
Revised after a check against the company's own annual filing.
Latest disclosed
10-Q filed 2026-08-05 · period ending 2026-06-30
Pieces naming this company
None yet.
No price is shown: the Index is a map of what each company sells and where it sits, not a quote board.